Mark DeCoster

Dr. Mark DeCoster

Louisiana Tech University
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Acta Biomaterialia
Verified
Journal Article
Closed access
QXQi Xing
Qi Xing
FZFeng Zhao
Feng Zhao
SCSi Chen
Si Chen
JMJames McNamara
James McNamara
MDMark DeCoster
Mark DeCoster
YLYuri Lvov
Yuri Lvov

1 April 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
GPGaurav Parekh
Gaurav Parekh
PPPravin Pattekari
Pravin Pattekari
CJChaitanya Joshi
Chaitanya Joshi
TSTatsiana Shutava
Tatsiana Shutava
MDMark DeCoster
Mark DeCoster
YLYuri Lvov
Yuri Lvov

1 February 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
JSJessica L. Scoggin
Jessica L. Scoggin
CTChao Tan
Chao Tan
NNNam H. Nguyen
Nam H. Nguyen
UKUrna Kansakar
Urna Kansakar
MMMahboubeh Madadi
Mahboubeh Madadi
Teresa Ann MurrayTeresa Ann Murray
Teresa Ann Murray

1 September 2011 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
SKSenaka K. Kanakamedala
Senaka K. Kanakamedala
HAHaidar T. Alshakhouri
Haidar T. Alshakhouri
MAMangilal Agarwal
Mangilal Agarwal
MDMark DeCoster
Mark DeCoster

14 May 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
MSMahdi Yar Saleh
Mahdi Yar Saleh
NPNeela Prajapati
Neela Prajapati
MDMark DeCoster
Mark DeCoster
YLYuri Lvov
Yuri Lvov
Neurological disorders that are characterized by unpredictable seizures affect people of all ages. We proposed the use of nanocarriers such as halloysite nanotubes to penetrate the blood–brain barrier and effectively deliver the payload over an extended time period. These 50-nm diameter tubes are a natural biocompatible nanomaterial available in large quantities. We proved a prolonged gradual drug delivery mechanism by the nanotube encapsulating rhodamine isothiocyanate and then ionomycin into brain microvascular endothelial cells (BMVECs). Through delayed diffusion, the nanotubes effectively delivered the drug to the primary BMVECs without killing them, by binding and penetration in time periods of 1 to 24 h.

15 September 1998 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
FOField Ogden
Field Ogden
MDMark DeCoster
Mark DeCoster
NBNicolas G. Bazan
Nicolas G. Bazan